Sabra Health Care REIT Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 7 out of 187 in the Residential & Commercial REITs industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 22.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Sabra Health Care REIT Inc is 8.33, ranking 43 out of 187 in the Residential & Commercial REITs industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 221.75M, representing a year-over-year increase of 20.82%, while its net profit experienced a year-over-year increase of 1.43%.
Key Metrics
The current valuation score of Sabra Health Care REIT Inc is 8.26, ranking 66 out of 187 in the Residential & Commercial REITs industry. Its current P/E ratio is 32.89, which is 654.72% below the recent high of 248.24 and 225.40% above the recent low of -41.25.
The current earnings forecast score of Sabra Health Care REIT Inc is 7.29, ranking 75 out of 187 in the Residential & Commercial REITs industry. The average price target is 21.00, with a high of 22.00 and a low of 20.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Sabra Health Care REIT Inc is 9.13, ranking 39 out of 187 in the Residential & Commercial REITs industry. Currently, the stock price is trading between the resistance level at 21.51 and the support level at 19.93, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Sabra Health Care REIT Inc is 10.00, ranking 1 out of 187 in the Residential & Commercial REITs industry. The latest institutional shareholding proportion is 119.91%, representing a quarter-over-quarter increase of 16.96%. The largest institutional shareholder is Invesco, holding a total of 1.92M shares, representing 0.76% of shares outstanding, with 12.64% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Residential & Commercial REITs domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sabra Health Care REIT Inc is 9.71, ranking 33 out of 187 in the Residential & Commercial REITs industry. The company's beta value is 0.65. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Sabra Health Care REIT Inc’s latest ESG disclosure leads the Residential & Commercial REITs industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
